奥普科健康

最新新闻

• 评级变动
  Opko Health (OPK) Receives a Buy From H.C. Wainwright
  TipRanks · 2023/8/7
• 评级变动
  H.C. Wainwright Sticks to Their Buy Rating for Opko Health (OPK)
  TipRanks · 2026/5/27
• 评级变动
  H.C. Wainwright Reaffirms Their Buy Rating on Opko Health (OPK)
  TipRanks · 2026/3/2
• 评级变动
  Analysts Are Bullish on These Healthcare Stocks: Opko Health (OPK), Sagimet Biosciences, Inc. Class A (SGMT)
  TipRanks · 2023/9/29
• Barrington Maintains Opko Health(OPK.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/7/28
• Analysts Offer Insights on Healthcare Companies: Opko Health (OPK) and Adlai Nortye Ltd. Sponsored ADR (ANL)
  TipRanks · 2026/10/16
• 评级变动
  A Quick Look at Today's Ratings for Opko Health(OPK.US), With a Forecast Between $1.6 to $3
  \u5e02\u573a\u8d44\u8baf · 2025/10/31
• 评级变动
  Analysts Offer Insights on Healthcare Companies: MDxHealth (MDXH), Opko Health (OPK) and Zenas BioPharma, Inc. (ZBIO)
  TipRanks · 2026/8/14
• 评级变动
  Jefferies Maintains Opko Health(OPK.US) With Hold Rating, Maintains Target Price $1.6
  \u5e02\u573a\u8d44\u8baf · 2025/10/31
• 评级变动
  Barrington Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $2.25
  \u5e02\u573a\u8d44\u8baf · 2025/10/30
• 评级变动
  Barrington Downgrades Opko Health(OPK.US) to Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/4/29
• 评级变动
  J.P. Morgan Initiates Opko Health(OPK.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2025/11/20
• Barrington Upgrades Opko Health(OPK.US) to Buy Rating, Announces Target Price $2.25
  \u5e02\u573a\u8d44\u8baf · 2026/10/17
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), Opko Health (OPK) and Leafly Holdings, Inc. (LFLY)
  TipRanks · 2024/4/1
• 评级变动
  Jefferies Initiates Opko Health(OPK.US) With Buy Rating, Announces Target Price $2
  \u5e02\u573a\u8d44\u8baf · 2025/3/14
• 评级变动
  Opko Health (OPK) Gets a Buy From H.C. Wainwright
  TipRanks · 2023/3/9
• Piper Sandler Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $3
  \u5e02\u573a\u8d44\u8baf · 2026/7/28
• H.C. Wainwright Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $3
  \u5e02\u573a\u8d44\u8baf · 2026/10/16
• 评级变动
  Barrington Maintains Opko Health(OPK.US) With Buy Rating, Cuts Target Price to $1.5
  \u5e02\u573a\u8d44\u8baf · 2026/3/2
• H.C. Wainwright Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $3
  \u5e02\u573a\u8d44\u8baf · 2026/8/14

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。